| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ACCELERON PHARMA | 162,070 | 4,036,000 | 43.03% | ||
| 2 | BioDelivery Sciences International Inc | 494,468 | 2,749,000 | 29.31% | ||
| 3 | Orexigen Therapeutics, Inc. | 1,229,287 | 2,594,000 | 27.66% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-15-065110, filed 2015.11.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
